Inspire Medical Systems, Inc. to Report Third Quarter 2024 Financial Results on November 4, 2024

Core Viewpoint - Inspire Medical Systems, Inc. will release its financial results for Q3 2024 on November 4, 2024, after market close, followed by a conference call to discuss the results and recent business developments [1]. Financial Results Announcement - The financial results for Q3 2024 will be announced after the close of trading on November 4, 2024 [1]. - A conference call will be held at 5:00 p.m. Eastern Time on the same day to discuss the results [1]. Conference Call Details - A webcast of the conference call will be available on the Investor Relations page of Inspire's website [2]. - For those wishing to ask questions, registration is required, and an email with dial-in details will be sent after registration [3]. - It is recommended to register at least 10 minutes before the call starts to ensure connection [3]. Replay Information - A replay of the conference call will be available on the Company's Investor Relations website approximately two hours after the event and will be archived for two weeks [4]. Company Overview - Inspire Medical Systems focuses on developing and commercializing innovative, minimally invasive solutions for obstructive sleep apnea [5]. - The company's proprietary Inspire therapy is the first and only FDA, EU MDR, and PDMA-approved neurostimulation technology for treating moderate to severe obstructive sleep apnea [5].